Pablo Tussy-Fernandez
Bizkaia Technology Park
Derio, PV, Spain
Derio, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progression.
Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression.
Journal: JCI insight
Published: January 04, 2023
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen.
Journal: Antioxidants (Basel, Switzerland)
Published: March 29, 2022
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity.
Journal: Cell death & disease
Published: January 09, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
Journal: JHEP reports : innovation in hepatology
Published: May 14, 2020
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
Journal: Nature communications
Published: June 19, 2019
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.
Journal: Cell metabolism
Published: June 25, 2018
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.
Journal: EBioMedicine
Published: June 13, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
Journal: Cell death & disease
Published: June 01, 2018
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury.
Journal: Nature communications
Published: February 24, 2017
Last Updated: 09/26/2026